What is LOPJLB’s current signal on IMNN?

LOPJLB’s latest quantitative signal on Imunon, Inc. (IMNN) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is IMNN in?

Imunon, Inc. (IMNN) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Imunon, Inc. (IMNN) do?

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, curren…

Imunon, Inc. (IMNN)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.04-2.80%Close

SELLCRISIS · day 15

[SCORES & PROFILE]

FUND: 4
VALUE: 6
GROWTH: 37
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-188.9%

REV YoY-

ROE-314.9%

EPS YoY-

ROA-98.2%

GROSS

NET

[VALUATION]

P/E TTM-0.23

P/E FWD-

SECTOR PE20.48

INDUSTRY PE13.99

P/B1.30

P/FCF-

EV/EBITDA-0.38

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E187.29

ALTMAN Z-

CURR RATIO1.82

ND/EBITDA-

BETA2.00

FAQ

What is LOPJLB’s current signal on IMNN?: LOPJLB’s latest quantitative signal on Imunon, Inc. (IMNN) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is IMNN in?: Imunon, Inc. (IMNN) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does Imunon, Inc. (IMNN) do?: Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, curren…

Imunon, Inc. (IMNN)

Key stats

Prediction markets

FUNDAMENTALS

Company news

FAQ